BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Itoh K, Ishihara Y, Komori R, Nochi H, Taniguchi R, Chiba Y, Ueno M, Takata-Tsuji F, Dohgu S, Kataoka Y. Levetiracetam treatment influences blood-brain barrier failure associated with angiogenesis and inflammatory responses in the acute phase of epileptogenesis in post-status epilepticus mice. Brain Res 2016;1652:1-13. [PMID: 27693413 DOI: 10.1016/j.brainres.2016.09.038] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Ishihara Y, Itoh K, Tanaka M, Tsuji M, Kawamoto T, Kawato S, Vogel CFA, Yamazaki T. Potentiation of 17β-estradiol synthesis in the brain and elongation of seizure latency through dietary supplementation with docosahexaenoic acid. Sci Rep 2017;7:6268. [PMID: 28740157 DOI: 10.1038/s41598-017-06630-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
2 Meng Y, Wu J, Shi J, Weng W, Zhou Z. Comparison of the safety of brivaracetam at various doses among patients with epilepsy: A network meta-analysis of randomized controlled trials. Exp Ther Med 2020;20:133. [PMID: 33082865 DOI: 10.3892/etm.2020.9262] [Reference Citation Analysis]
3 Ismail FS, Corvace F, Faustmann PM, Faustmann TJ. Pharmacological Investigations in Glia Culture Model of Inflammation. Front Cell Neurosci 2021;15:805755. [PMID: 34975415 DOI: 10.3389/fncel.2021.805755] [Reference Citation Analysis]
4 Contreras-garcía IJ, Cárdenas-rodríguez N, Romo-mancillas A, Bandala C, Zamudio SR, Gómez-manzo S, Hernández-ochoa B, Mendoza-torreblanca JG, Pichardo-macías LA. Levetiracetam Mechanisms of Action: From Molecules to Systems. Pharmaceuticals 2022;15:475. [DOI: 10.3390/ph15040475] [Reference Citation Analysis]
5 Bankstahl M, Breuer H, Leiter I, Märkel M, Bascuñana P, Michalski D, Bengel FM, Löscher W, Meier M, Bankstahl JP, Härtig W. Blood-Brain Barrier Leakage during Early Epileptogenesis Is Associated with Rapid Remodeling of the Neurovascular Unit. eNeuro 2018;5:ENEURO. [PMID: 29854942 DOI: 10.1523/ENEURO.0123-18.2018] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 5.3] [Reference Citation Analysis]
6 Alavi MS, Fanoudi S, Hosseini M, Sadeghnia HR. Beneficial effects of levetiracetam in streptozotocin-induced rat model of Alzheimer’s disease. Metab Brain Dis. [DOI: 10.1007/s11011-021-00888-0] [Reference Citation Analysis]
7 Eastman CL, Fender JS, Klein P, D'Ambrosio R. Therapeutic Effects of Time-Limited Treatment with Brivaracetam on Posttraumatic Epilepsy after Fluid Percussion Injury in the Rat. J Pharmacol Exp Ther 2021;379:310-23. [PMID: 34593559 DOI: 10.1124/jpet.121.000585] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Klein P, Friedman A, Hameed MQ, Kaminski RM, Bar-Klein G, Klitgaard H, Koepp M, Jozwiak S, Prince DA, Rotenberg A, Twyman R, Vezzani A, Wong M, Löscher W. Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy? Epilepsia 2020;61:359-86. [PMID: 32196665 DOI: 10.1111/epi.16450] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
9 Inaba T, Miyamoto N, Hira K, Ueno Y, Yamashiro K, Watanabe M, Shimada Y, Hattori N, Urabe T. Protective Role of Levetiracetam Against Cognitive Impairment And Brain White Matter Damage in Mouse prolonged Cerebral Hypoperfusion. Neuroscience 2019;414:255-64. [PMID: 31302262 DOI: 10.1016/j.neuroscience.2019.07.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
10 Yamazaki A, Shue F, Yamazaki Y, Martens YA, Bu G, Liu CC. Preparation of single cell suspensions enriched in mouse brain vascular cells for single-cell RNA sequencing. STAR Protoc 2021;2:100715. [PMID: 34401781 DOI: 10.1016/j.xpro.2021.100715] [Reference Citation Analysis]
11 Bicker J, Alves G, Fonseca C, Falcão A, Fortuna A. Repairing blood-CNS barriers: Future therapeutic approaches for neuropsychiatric disorders. Pharmacol Res 2020;162:105226. [PMID: 33007420 DOI: 10.1016/j.phrs.2020.105226] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Yan BC, Xu P, Gao M, Wang J, Jiang D, Zhu X, Won MH, Su PQ. Changes in the Blood-Brain Barrier Function Are Associated With Hippocampal Neuron Death in a Kainic Acid Mouse Model of Epilepsy. Front Neurol 2018;9:775. [PMID: 30258402 DOI: 10.3389/fneur.2018.00775] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
13 Santana-Gómez CE, Valle-Dorado MG, Domínguez-Valentín AE, Hernández-Moreno A, Orozco-Suárez S, Rocha L. Neuroprotective effects of levetiracetam, both alone and combined with propylparaben, in the long-term consequences induced by lithium-pilocarpine status epilepticus. Neurochem Int 2018;120:224-32. [PMID: 30213635 DOI: 10.1016/j.neuint.2018.09.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
14 Victor TR, Tsirka SE. Microglial contributions to aberrant neurogenesis and pathophysiology of epilepsy. Neuroimmunol Neuroinflamm 2020;7:234-47. [PMID: 33154976 DOI: 10.20517/2347-8659.2020.02] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Niidome K, Taniguchi R, Yamazaki T, Tsuji M, Itoh K, Ishihara Y. FosL1 Is a Novel Target of Levetiracetam for Suppressing the Microglial Inflammatory Reaction. Int J Mol Sci 2021;22:10962. [PMID: 34681621 DOI: 10.3390/ijms222010962] [Reference Citation Analysis]
16 Ishihara Y, Itoh K, Oguro A, Chiba Y, Ueno M, Tsuji M, Vogel CFA, Yamazaki T. Neuroprotective activation of astrocytes by methylmercury exposure in the inferior colliculus. Sci Rep 2019;9:13899. [PMID: 31554907 DOI: 10.1038/s41598-019-50377-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
17 Yao X, Yang W, Ren Z, Zhang H, Shi D, Li Y, Yu Z, Guo Q, Yang G, Gu Y, Zhao H, Ren K. Neuroprotective and Angiogenesis Effects of Levetiracetam Following Ischemic Stroke in Rats. Front Pharmacol 2021;12:638209. [PMID: 34054520 DOI: 10.3389/fphar.2021.638209] [Reference Citation Analysis]
18 Itoh K, Taniguchi R, Matsuo T, Oguro A, Vogel CFA, Yamazaki T, Ishihara Y. Suppressive effects of levetiracetam on neuroinflammation and phagocytic microglia: A comparative study of levetiracetam, valproate and carbamazepine. Neurosci Lett 2019;708:134363. [PMID: 31276728 DOI: 10.1016/j.neulet.2019.134363] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
19 Takamatsu T, Yamanaka G, Uryu H, Takeshita M, Morishita N, Morichi S, Ishida Y, Oana S, Terashi H, Shichino H, Sakuma H, Kawashima H. Improvement in recurrent anti-myelin oligodendrocyte glycoprotein antibody - positive cerebral cortical encephalitis not requiring anti - inflammatory therapy following the decrease in cytokine/chemokine levels. Multiple Sclerosis and Related Disorders 2020;43:102168. [DOI: 10.1016/j.msard.2020.102168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
20 Bleck TP. How Critical Illness Affects the Brain…and Vice Versa. Crit Care Med 2018;46:465-70. [PMID: 29474329 DOI: 10.1097/CCM.0000000000002944] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]